Effect of Beverages Containing Different Doses of Alginate Fibers on Appetite, Energy Intake and Glycemia
NCT ID: NCT01720784
Last Updated: 2014-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2012-10-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Here we test three different beverages in a double-blinded crossover design, in which 24 participants will be randomly assigned to the sequence of the test days separated by at least 5 days.
On each test day appetite sensation as well as blood glucose and insulin will be measured over 4h after intake of the test product. Hereafter, an ad libitum meal consisting of Pasta Bolognese will be served, and energy intake calculated. The participants will also rate gastrointestinal confort.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Sodium Alginate on Appetite Sensation
NCT01101633
The Effect of Alginate Supplementation on Weight Management
NCT04589273
Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties
NCT07127198
Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers
NCT00958399
The Effect of Soluble Fiber Dextrin on Subjective and Physiological Markers of Appetite
NCT04596969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On each test day, the participants will meet at the department in a fasting state. After voiding they will be weighed, and a venflon catheter will be inserted in the antecubital vein, allowing repeated blood sampling throughout the test day. Baseline measurements of blood pressure, blood samples, and visual analogue scales (VAS) scores will be conducted at time point of -15 min. A second baseline blood sample will be drawn at time point 0, immediately after which the participants will consume the preload beverage (time point 0) with a 10 min time limit for consumption. After consumption of the preload beverage, blood samples will be taken and VAS scores completed at time points 15 and 30 min, and hereafter the he standardized breakfast will be served for which 15 minutes is allowed (time point 30 min). After the participants have finished the breakfast, blood samples will be drawn and VAS scores completed at time points 45, 60, 90, 120, 180, 210 and 240 min.
Hereafter, an ad libitum meal consisting of Pasta Bolognese will be served, and energy intake calculated, and the final VAS score will be completed at time point 270 min after the participants have finished their lunch. Before leaving, the participants will fill in a questionnaire related to gastrointestinal adverse events (AE).
As a pilot study, the first 6 participants to finish the study will be invited to participate in a fourth test day, on which capsules containing alginate fibers will be administered together with the placebo beverage. This fourth test day is not included in the randomization and will not be blinded for the participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Placebo
Low dose (1.5 g DF)
Alginate dietary fiber
High dose (2.25 gDF)
Alginate dietary fiber
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alginate dietary fiber
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Smoking
* Use of dietary supplements up to 1 month before the first meal test
* Pregnancy or lactation
* Daily use of prescription medication (except for oral contraceptives)
* Any known chronic illnesses
* Participation in other intervention studies
* Non-adherence to the protocol or lack of cooperation
* Blood donation within 3 months prior to the study
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
S-Biotek Holding ApS
OTHER
Arne Astrup
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arne Astrup
Head of Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nutrition, Exercise and Sports, University of Copenhagen
Frederiksberg C, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B295
Identifier Type: -
Identifier Source: secondary_id
H-3-2012-101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.